GoodRx Holdings and Criteo Corp agreed to pay $32 million to settle a class action that alleged the prescription pricing monitor shared sensitive personal information with third party advertising and social media sites.
The settlement, if approved by the US District Court for the Northern District of California, would represent “approximately 21 times” the fine the Federal Trade Commission recovered from GoodRx based on similar improper info sharing allegations, according to a motion for preliminary approval. Google and Meta Platforms, who are co-defendants in the California case, are not part of the settlement.
GoodRx users with an approved claim will ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
